Our Recommendations
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
New Publications
- Clinical management and infection prevention and control for mpox: living guideline, May 2025 (2025)
- Performance of Certest Biotec’s VIASURE yellow fever real time PCR detection kit (2025)
- Banque de questionspour le personnel de santé lors épidemiés de maladies infectieuse (2025)
- Questions bank for healthcare workers during infectious disease outbreaks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
Filter
909
Featured
Recommendations
159
New Publications
237
Language
Document type
No document type
425
Guidelines
134
Training Material
51
Manuals
44
Situation Updates
42
Fact sheets
42
Studies & Reports
39
Online Courses
38
Strategic & Response Plan
31
Infographics
29
Resource Platforms
22
Videos
11
Dashboards/Maps
1
Countries / Regions
Congo, Democratic Republic of
32
Brazil
27
Nigeria
23
Guinea
23
Sierra Leone
21
Africa
21
Liberia
20
Madagascar
20
Latin America and the Carribbean
19
Senegal
18
Global
18
Burkina Faso
17
Rwanda
16
Côte d’Ivoire / Ivory Coast
14
Germany
13
Angola
12
Mozambique
11
Western and Central Europe
11
Russia
11
Mali
11
West and Central Africa
9
India
9
Uganda
8
Indonesia
8
Ghana
7
Syria
7
Ethiopia
7
East and Southern Africa
6
South Africa
6
Somalia
6
Paraguay
5
Portugal
5
Yemen
5
Chad
5
South Sudan
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Argentina
4
Vietnam
4
Sri Lanka
4
China
3
Cameroon
3
Niger
3
Central African Republic
3
Nepal
2
Afghanistan
2
Zimbabwe
2
USA
2
Asia
2
Venezuela
2
Bolivia
2
Bangladesh
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
149
Key Resources
149
Countries
105
Public Health
60
Capacity Building
49
Pharmacy & Technologies
33
Women & Child Health
4
Given the circulation of the variant of clade I of mpox virus (MPXV) in the African Region, which is associated in the African Region with sustained transmission and the occurrence of cases in a wider range of age groups, including children, the Pan American Health Organization/World Health Organiza...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
Situation Update
En décembre 2022, la République démocratique du Congo a déclaré une flambée nationale de variole simienne. Un système de gestion des incidents est en place depuis février 2023, compte tenu du nombre croissant de cas signalés. Depuis septembre 2023, l’épidémie de variole simienne continu...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
mise à jour de la situation
Outbeak of Clade I MPXV in Subsaharan Africa
The tab is the result of a preliminary landscape of vaccines licensed or under development for Mpox
El Director General de la OMS, Dr. Tedros Adhanom Ghebreyesus, ha determinado que el recrudecimiento de la viruela símica (mpox) en la República Democrática del Congo y en un número creciente de países de África constituye una emergencia de salud pública de importancia internacional (ESPII) c...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
En esta nota técnica se explican los 20 aspectos que deben considerarse para evaluar el estado y la seguridad del equipo y los suministros de laboratorio. No se incluyen en este trabajo las instrucciones para los evaluadores de los puntos 93 (Estado y seguridad del equipo médico en las salas de op...
Hand hygiene is vital for safe health care delivery, yet practices at the point of care remain suboptimal worldwide. A comprehensive research agenda is therefore necessary to improve our understanding of factors influencing hand hygiene behaviour and to strengthen appropriate interventions. This age...
DOWNLOAD (1.13 MB)
Many people with dengue can be cared for at home with adequate rest and hydration. But, if you experience any warning signs, go immediately to the nearest medical center.
Une flambée de maladie connue sous le nom de « variole du singe » sévit actuellement dans de nombreux pays où il n’y a généralement pas de cas. Cette situation peut être préoccupante, notamment pour les personnes dont les proches ou la communauté sont touchés. Certains cas ont été obs...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
Las olas de transmisión de la fiebre amarilla ocurridas en la Región de las Américas entre el 2016 y el 2018 causaron el mayor número de casos humanos y epizoóticos registrados en varios decenios. La fiebre amarilla es una enfermedad hemorrágica viral grave que representa un desafío para el p...
